Isocratic Separation of NSAIDs on HALO® ES-CN Phase
Bonded Phase: ES-CN
Market Segment: Pharmaceuticals
Particle Size: 2.7 µm
Pore Size: 90 Å
Product Segment: SMALL MOLECULE
Separation Mode: Reversed Phase
USP Number: L10
Download FileBonded Phase: ES-CN
Market Segment: Pharmaceuticals
Particle Size: 2.7 µm
Pore Size: 90 Å
Product Segment: SMALL MOLECULE
Separation Mode: Reversed Phase
USP Number: L10
Download File